An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC.
- DOI
- 10.3389/fimmu.2026.1854773
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1854773,
title = {An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC.},
author = {Li S and Du F and Leng C and Dou J and Shi J and Zhang Y and Lu F and Wang Q},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1854773},
url = {https://doi.org/10.3389/fimmu.2026.1854773}
}RIS
TY - JOUR TI - An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC. AU - Li S AU - Du F AU - Leng C AU - Dou J AU - Shi J AU - Zhang Y AU - Lu F AU - Wang Q PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1854773 UR - https://doi.org/10.3389/fimmu.2026.1854773 ER -
APA
S, L., F, D., C, L., J, D., J, S., Y, Z., F, L., & Q, W. (2026). An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1854773
Source records
- pubmed · retrieved 2026-09-25T13:12:01.357Z
- europe-pmc · retrieved 2026-09-25T13:12:01.366Z
- doaj · retrieved 2026-09-25T13:12:01.380Z